Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
about
Scavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyClinical significance of sCD163 and its possible role in asthma (Review).Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges.Elevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndromeTumor-associated macrophages: from basic research to clinical application.Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.Preoperative serum macrophage activated biomarkers soluble mannose receptor (sMR) and soluble haemoglobin scavenger receptor (sCD163), as novel markers for the diagnosis and prognosis of gastric cancer.Nurse-like cells impact on disease progression in chronic lymphocytic leukemia.Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia.Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma.CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer.CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma.Prognostic role of M2 tumour-associated macrophages in lymphoproliferative disorders.Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma.Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.Antibody dependent cellular phagocytosis by macrophages is a novel mechanism of action of elotuzumab.Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis.
P2860
Q26799114-42BBE393-DB6E-4EE5-A664-74FFABB9B6F1Q33674640-41207D7B-94CD-4849-98A2-C32DE133A956Q33935498-003EE667-8349-4B82-9D3D-B9852A3AB3CCQ34505966-84D9049A-F1EB-458A-900F-195AA3CCD187Q37671174-0052FCA6-DBB3-41D3-AC0C-9D5B7AF1C760Q38824039-944B919D-97FD-4F58-AC20-E68B6432B417Q41612982-0FB81E16-18C4-4833-B258-53A6D888AB32Q42553277-C320D444-1AEE-4948-AB95-A4966D6DA961Q43813493-240F6D67-8385-47FA-92C7-9DF9F1170C11Q44890085-B329C14C-CCC4-4996-A75D-674E58B0AA9BQ45874696-3CFDFB26-3FA2-4C9D-9995-E041CE6344BDQ47125786-EA2B8049-25F0-4E49-AE5D-101EF33A7462Q48201715-365848F8-A5EC-4686-852D-D3BF3D1123B0Q48515598-FF9D9915-A378-48C9-B0DF-93255B76B81CQ49130713-FC54760C-9E7C-4356-968B-9942FE08B853Q49954049-6257FB91-003C-44AC-A4F6-B35E714D7B7DQ50545382-8BC7DB3A-4997-48A0-BCEA-871C2B579EFDQ52589219-B0E21E8D-F3D4-4EAB-848C-F3402CB1E7B0Q55340253-64A4D647-1D93-4727-9A0E-4D4091194F72
P2860
Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
@en
Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
@nl
type
label
Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
@en
Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
@nl
prefLabel
Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
@en
Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
@nl
P2093
P2860
P356
P1476
Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
@en
P2093
Holger J Møller
Maciej B Maniecki
Morten N Andersen
Niels Abildgaard
Niels F Andersen
P2860
P356
10.1111/EJH.12296
P577
2014-03-20T00:00:00Z